CI vs PRCT · P/E 2.4, rev $274.90B vs rev $224.5M
Cigna Corp (CI) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the CI and PRCT stock pages for the full models.
Not investment advice.